1. Home
  2. CLMT vs HROW Comparison

CLMT vs HROW Comparison

Compare CLMT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calumet Specialty Products Partners L.P.

CLMT

Calumet Specialty Products Partners L.P.

HOLD

Current Price

$28.58

Market Cap

2.1B

Sector

Energy

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$34.10

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMT
HROW
Founded
1916
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
CLMT
HROW
Price
$28.58
$34.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$23.25
$71.14
AVG Volume (30 Days)
1.4M
924.6K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
85.39
N/A
EPS
N/A
N/A
Revenue
$4,137,100,000.00
N/A
Revenue This Year
$4.45
$44.68
Revenue Next Year
N/A
$40.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.68
$20.85
52 Week High
$31.41
$54.98

Technical Indicators

Market Signals
Indicator
CLMT
HROW
Relative Strength Index (RSI) 55.64 27.80
Support Level $17.31 $30.55
Resistance Level $30.67 $40.64
Average True Range (ATR) 1.58 2.54
MACD -0.30 -1.45
Stochastic Oscillator 44.01 2.31

Price Performance

Historical Comparison
CLMT
HROW

About CLMT Calumet Specialty Products Partners L.P.

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: